Peringatan Keamanan

Lowest published lethal dose in rat via oral route is 22000 mg/kg MSDS. Cases of hyperkalemia have been reported with ingestion of a large quantity of potassium bitartrate A33010.

Potassium bitartrate

DB11107

small molecule experimental

Deskripsi

Potassium bitartate, also referred to as potassium acid tartrate or cream of tartar, is the potassium acid salt of l-( + )-tartaric acid. It is obtained as a byproduct of wine manufacture during the fermentation process. Approved by the FDA as a direct food substance, potassium bitartrate is used as an additive, stabilizer, pH control agent, antimicrobial agent, processing aid, or thickener in various food products L2732. Potassium bitartrate has a long history of medical use as a laxative administered as a rectal suppository and is an approved third-class OTC drug in Japan.

Potassium bitartrate was one of active ingredients in Phexxi, a non-hormonal contraceptive agent that was approved by the FDA on May 2020.L14120

Struktur Molekul 2D

Berat 188.176
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) No pharmacokinetic data available.
Volume Distribusi No pharmacokinetic data available.
Klirens (Clearance) No pharmacokinetic data available.

Absorpsi

There is little systemic absorption expected following rectal administration of potassium bitartrate.

Metabolisme

No pharmacokinetic data available.

Rute Eliminasi

No pharmacokinetic data available.

Interaksi Obat

611 Data
Ramipril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Ramipril.
Fosinopril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Fosinopril.
Trandolapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Trandolapril.
Benazepril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Benazepril.
Enalapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Enalapril.
Moexipril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Moexipril.
Lisinopril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Lisinopril.
Perindopril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Perindopril.
Quinapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Quinapril.
Omapatrilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Omapatrilat.
Rescinnamine The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Rescinnamine.
Captopril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Captopril.
Cilazapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Cilazapril.
Spirapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Spirapril.
Temocapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Temocapril.
Enalaprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Enalaprilat.
Imidapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Imidapril.
Zofenopril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Zofenopril.
Delapril The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Delapril.
Benazeprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Benazeprilat.
Fosinoprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Fosinoprilat.
Ramiprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Ramiprilat.
Trandolaprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Trandolaprilat.
Moexiprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Moexiprilat.
Perindoprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Perindoprilat.
Quinaprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Quinaprilat.
Cilazaprilat The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Cilazaprilat.
Triamterene The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Triamterene.
Spironolactone The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Spironolactone.
Amiloride The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Amiloride.
Eplerenone The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Eplerenone.
Canrenoic acid The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Canrenoic acid.
Canrenone The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Canrenone.
Valsartan Potassium bitartrate may increase the hyperkalemic activities of Valsartan.
Olmesartan Potassium bitartrate may increase the hyperkalemic activities of Olmesartan.
Losartan Potassium bitartrate may increase the hyperkalemic activities of Losartan.
Candesartan cilexetil Potassium bitartrate may increase the hyperkalemic activities of Candesartan cilexetil.
Eprosartan Potassium bitartrate may increase the hyperkalemic activities of Eprosartan.
Telmisartan Potassium bitartrate may increase the hyperkalemic activities of Telmisartan.
Irbesartan Potassium bitartrate may increase the hyperkalemic activities of Irbesartan.
Forasartan Potassium bitartrate may increase the hyperkalemic activities of Forasartan.
Saprisartan Potassium bitartrate may increase the hyperkalemic activities of Saprisartan.
Tasosartan Potassium bitartrate may increase the hyperkalemic activities of Tasosartan.
Saralasin Potassium bitartrate may increase the hyperkalemic activities of Saralasin.
Azilsartan medoxomil Potassium bitartrate may increase the hyperkalemic activities of Azilsartan medoxomil.
Fimasartan Potassium bitartrate may increase the hyperkalemic activities of Fimasartan.
Candesartan Potassium bitartrate may increase the hyperkalemic activities of Candesartan.
Cyclosporine Potassium bitartrate may increase the hyperkalemic activities of Cyclosporine.
Icosapent Potassium bitartrate may increase the hyperkalemic activities of Icosapent.
Esmolol Potassium bitartrate may increase the hyperkalemic activities of Esmolol.
Betaxolol Potassium bitartrate may increase the hyperkalemic activities of Betaxolol.
Fluconazole Potassium bitartrate may increase the hyperkalemic activities of Fluconazole.
Succinylcholine Potassium bitartrate may increase the hyperkalemic activities of Succinylcholine.
Mesalazine Potassium bitartrate may increase the hyperkalemic activities of Mesalazine.
Metoprolol Potassium bitartrate may increase the hyperkalemic activities of Metoprolol.
Isradipine Potassium bitartrate may increase the hyperkalemic activities of Isradipine.
Indomethacin Potassium bitartrate may increase the hyperkalemic activities of Indomethacin.
Atenolol Potassium bitartrate may increase the hyperkalemic activities of Atenolol.
Diltiazem Potassium bitartrate may increase the hyperkalemic activities of Diltiazem.
Trimethadione Potassium bitartrate may increase the hyperkalemic activities of Trimethadione.
Timolol Potassium bitartrate may increase the hyperkalemic activities of Timolol.
Amlodipine Potassium bitartrate may increase the hyperkalemic activities of Amlodipine.
Digoxin Potassium bitartrate may increase the hyperkalemic activities of Digoxin.
Nimodipine Potassium bitartrate may increase the hyperkalemic activities of Nimodipine.
Nisoldipine Potassium bitartrate may increase the hyperkalemic activities of Nisoldipine.
Ardeparin Potassium bitartrate may increase the hyperkalemic activities of Ardeparin.
Trimethoprim Potassium bitartrate may increase the hyperkalemic activities of Trimethoprim.
Nabumetone Potassium bitartrate may increase the hyperkalemic activities of Nabumetone.
Ketorolac Potassium bitartrate may increase the hyperkalemic activities of Ketorolac.
Tenoxicam Potassium bitartrate may increase the hyperkalemic activities of Tenoxicam.
Celecoxib Potassium bitartrate may increase the hyperkalemic activities of Celecoxib.
Sotalol Potassium bitartrate may increase the hyperkalemic activities of Sotalol.
Tolmetin Potassium bitartrate may increase the hyperkalemic activities of Tolmetin.
Lercanidipine Potassium bitartrate may increase the hyperkalemic activities of Lercanidipine.
Rofecoxib Potassium bitartrate may increase the hyperkalemic activities of Rofecoxib.
Piroxicam Potassium bitartrate may increase the hyperkalemic activities of Piroxicam.
Lamotrigine Potassium bitartrate may increase the hyperkalemic activities of Lamotrigine.
Cinnarizine Potassium bitartrate may increase the hyperkalemic activities of Cinnarizine.
Propranolol Potassium bitartrate may increase the hyperkalemic activities of Propranolol.
Fenoprofen Potassium bitartrate may increase the hyperkalemic activities of Fenoprofen.
Valdecoxib Potassium bitartrate may increase the hyperkalemic activities of Valdecoxib.
Diclofenac Potassium bitartrate may increase the hyperkalemic activities of Diclofenac.
Ethosuximide Potassium bitartrate may increase the hyperkalemic activities of Ethosuximide.
Labetalol Potassium bitartrate may increase the hyperkalemic activities of Labetalol.
Sulindac Potassium bitartrate may increase the hyperkalemic activities of Sulindac.
Bisoprolol Potassium bitartrate may increase the hyperkalemic activities of Bisoprolol.
Nicardipine Potassium bitartrate may increase the hyperkalemic activities of Nicardipine.
Magnesium sulfate Potassium bitartrate may increase the hyperkalemic activities of Magnesium sulfate.
Nitrofurantoin Potassium bitartrate may increase the hyperkalemic activities of Nitrofurantoin.
Flurbiprofen Potassium bitartrate may increase the hyperkalemic activities of Flurbiprofen.
Pentamidine Potassium bitartrate may increase the hyperkalemic activities of Pentamidine.
Mannitol The risk or severity of dehydration can be increased when Mannitol is combined with Potassium bitartrate.
Etodolac Potassium bitartrate may increase the hyperkalemic activities of Etodolac.
Potassium chloride Potassium bitartrate may increase the hyperkalemic activities of Potassium chloride.
Mefenamic acid Potassium bitartrate may increase the hyperkalemic activities of Mefenamic acid.
Naproxen Potassium bitartrate may increase the hyperkalemic activities of Naproxen.
Sulfasalazine Potassium bitartrate may increase the hyperkalemic activities of Sulfasalazine.
Phenylbutazone Potassium bitartrate may increase the hyperkalemic activities of Phenylbutazone.
Meloxicam Potassium bitartrate may increase the hyperkalemic activities of Meloxicam.
Carprofen Potassium bitartrate may increase the hyperkalemic activities of Carprofen.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 22926733
    Rusyniak DE, Durant PJ, Mowry JB, Johnson JA, Sanftleben JA, Smith JM: Life-threatening hyperkalemia from cream of tartar ingestion. J Med Toxicol. 2013 Mar;9(1):79-81. doi: 10.1007/s13181-012-0255-x.
  • PMID: 17532693
    Lazzaroni M, Casini V, Bianchi Porro G: Role or carbon dioxide-releasing suppositories in the treatment of chronic functional constipation: a double-blind, randomised, placebo-controlled trial. Clin Drug Investig. 2005;25(8):499-505.

Contoh Produk & Brand

Produk: 4 • International brands: 0
Produk
  • Ceo-two
    Suppository • - • Rectal • US • OTC
  • Ceo-two Bowel Evacuant Suppositories
    Suppository • - • Rectal • Canada • OTC • Approved
  • Phexx
    Gel • - • Vaginal • US • Approved
  • Phexxi
    Gel • - • Vaginal • US • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul